Cuff-Limited exercise may boost blood health in anemic young women

NCT ID NCT07701213

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study investigates whether combining aerobic exercise with blood flow restriction—using a pressure cuff on the thigh—can improve key blood markers in young women with iron deficiency anemia. Fifty participants aged 19-25 with mild to moderate anemia will walk on a treadmill three times a week for three months while wearing the cuff. Researchers will measure changes in hemoglobin, ferritin, and other blood factors, as well as functional capacity and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
aerobic exercise combined with blood flow restriction using a pressure cuff
What this could lead to
If effective, this approach could offer a non-drug way to improve anemia and quality of life in young women.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply broadly. The blood flow restriction technique carries risks like bruising or clotting in susceptible individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Hb more than 8 and less than 12 in females. 2. Age: 19-25 year. 3. BMI ranging from 25 to 29.9 kg/m2. 4. No existing inflammatory conditions including rheumatoid arthritis disorders of the lower extremities. 5. Physical activity level less than 150 min per week Exclusion Criteria: 1. unstable hypertension, venous thromboembolism, hypercoagulable states, varicose veins, pregnancy, and hemophilia. 2. inherited or acquired red cell disorders (haemoglobinopathies). 3. acute or chronic infections (malaria, tuberculosis, HIV),. 4. severe anemia (Hb \<8 g/dL). 5. History of cardiovascular diseases. 6. Nutritional anemia (B12/folate) 7. Pregnancy. 8. Peripheral arterial disease. 9. Intermittent claudication. 10. Non smokers

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Iron deficiency anaemia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.